DA
TMO icon

Doliver Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Doliver Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
4,069
+219
+6% +$105K 0.46% 31
2026
Q1 		$1.89M Buy
3,850
+39
+1% +$21.2K 0.43% 32
2025
Q4 		$2.21M Buy
3,811
+36
+1% +$20.4K 0.55% 26
2025
Q3 		$1.83M Buy
3,775
+33
+0.9% +$15.4K 0.47% 36
2025
Q2 		$1.52M Buy
3,742
+835
+29% +$349K 0.42% 39
2025
Q1 		$1.45M Buy
2,907
+104
+4% +$56.3K 0.41% 40
2024
Q4 		$1.46M Buy
2,803
+44
+2% +$24.2K 0.41% 41
2024
Q3 		$1.71M Sell
2,759
-78
-3% -$46.2K 0.47% 35
2024
Q2 		$1.57M Buy
2,837
+21
+0.7% +$12K 0.44% 37
2024
Q1 		$1.64M Sell
2,816
-18
-0.6% -$10.1K 0.46% 35
2023
Q4 		$1.5M Buy
2,834
+35
+1% +$16.9K 0.46% 39
2023
Q3 		$1.42M Sell
2,799
-33
-1% -$17.6K 0.43% 35
2023
Q2 		$1.48M Buy
2,832
+140
+5% +$75.5K 0.45% 32
2023
Q1 		$1.55M Buy
2,692
+120
+5% +$67.6K 0.49% 30
2022
Q4 		$1.42M Buy
2,572
+44
+2% +$23.3K 0.47% 33
2022
Q3 		$1.28M Buy
2,528
+168
+7% +$94K 0.47% 30
2022
Q2 		$1.28M Buy
2,360
+461
+24% +$254K 0.46% 38
2022
Q1 		$1.12M Buy
1,899
+163
+9% +$93.6K 0.35% 52
2021
Q4 		$1.03M Sell
1,736
-629
-27% -$393K 0.32% 53
2021
Q3 		$1.35M Buy
2,365
+203
+9% +$111K 0.45% 41
2021
Q2 		$1.09M Buy
2,162
+542
+33% +$256K 0.36% 47
2021
Q1 		$739K Buy
1,620
+805
+99% +$384K 0.27% 63
2020
Q4 		$380K Buy
+815
New +$382K 0.17% 89

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Doliver Advisors's TMO Position: Q2 2026 in Review

Doliver Advisors increased its Thermo Fisher Scientific (TMO) stake by 5.7% in Q2 2026, buying an estimated $105K and bringing the position to 4,069 shares worth $2.04M. The position accounts for 0.46% of the portfolio, ranked #31.

Doliver Advisors first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.21M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Doliver Advisors held 4,069 shares of Thermo Fisher Scientific worth $2.04M as of Q2 2026.
  • Doliver Advisors bought 219 Thermo Fisher Scientific shares in Q2 2026, an estimated $105K.
  • Thermo Fisher Scientific made up 0.46% of Doliver Advisors's portfolio in Q2 2026, its #31 holding.
  • Doliver Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Doliver Advisors's Thermo Fisher Scientific position peaked at $2.21M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Doliver Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.